Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class ASSE: 688076

"Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd."Announcement on Shareholding Reduction Plan by Certain Shareholders

Sep 16, 2026 · Issued by Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Shareholding Reduction Plan by Certain Shareholders

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A

"Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificates for Vonoprazan Fumarate Tablets and Glucosamine Sulfate CapsulesAug 26
"Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report and Q1 2026 ReportJul 10
"Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd."Announcement on Vesting Results for the 3rd Vesting Period under the 2023 Restricted Stock Incentive Plan and the Listing of SharesJul 9
Announcement on Meeting Vesting Conditions in 3rd Vesting Period in Restricted Stock Incentive Plan 2023Jun 27

All Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A news releases